Tracking T-Cell Repertoire Dynamics to Reveal Immunotherapy Response Biomarkers
See how high-resolution TCR sequencing and advanced profiling analytics captured meaningful therapeutic responses to autologous TIL therapy in patients with immunotherapy-resistant tumors — and how this approach can identify and validate TCR repertoire biomarkers that predict clinical benefit.
